Schedule 13G ownership disclosure

BIOLINERX LTD

Security class unavailable · CUSIP: 09071M205

Event date: 2020-05-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,142,857
Percent of class
6.6200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-20-000095
Form type
SC 13G
Filer
BioLineRx Ltd.
CIK
CIK 1498403
Filed
May 26, 2020
Reporting period
May 26, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub